Skip to content
★ Sign in to follow
VS

Vijay Satyanand Pande

Executive
Total declarations
8
Company
1
▲ Purchases (4 ops.)
€18.4M
▼ Sales (0 ops.)
—

Latest filing published 03 Oct 2024 for BioAge Labs, Inc., €1.2M.

Filing timeline

BuySale
Vijay Satyanand Pande

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
0%
Median T+90
-74.6%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Oct 2024 · 766 days ago · €1.2M
    -74.3%
    Entry US$21.89 · Close at T+365 US$5.63
  • Filed 27 Sept 2024 · 772 days ago · €14.5M
    -73.8%
    Entry US$20.80 · Close at T+365 US$5.45

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Vijay Satyanand Pande: trading record in brief

This profile gathers the share dealings of Vijay Satyanand Pande in BioAge Labs, Inc. Over a trading history stretching from 27 September 2024 to 3 October 2024, the count stands at 8 filings.

Every open-market trade on record is a purchase: 4 purchases worth €18.4M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €1.7M. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -74.6%. These figures describe past trades and do not predict future prices.

The record was last updated on 3 October 2024 with an open-market purchase (€1.2M) in BioAge Labs, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Vijay Satyanand Pande

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations